Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px
Organisation › Details

Genmab (Group)

Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. Founded in 1999, the company's first marketed antibody, ofatumumab (Arzerra®), was approved to treat chronic lymphocytic leukemia in patients who are refractory to fludarabine and alemtuzumab after less than eight years in development. Genmab's validated and next generation antibody technologies are expected to provide a steady stream of future product candidates. Partnering of innovative product candidates and technologies is a key focus of Genmab's strategy and the company has alliances with top tier pharmaceutical and biotechnology companies. *

 

Period Start 1999-01-01 established
  Today Genmab A/S (Nasdaq Copenhagen: GEN)
Products Industry DuoBody technology platform (bispecific antibodies)
  Industry 2 Darzalex®
Person Person van de Winkel, Jan (Genmab 201106 CEO before CSO + Co-Founder before Medarex Europe)
     
Region Region København (Copenhagen)
  Country Denmark
  Street 34 Bredgade
  City 1260 Copenhagen K
  Tel +45-70-202728
    Address record changed: 2018-07-24
     
Basic data Employees D: 101 to 500 (2016-12-31)
  Currency DKK
  Annual sales 1,816,122,000 (revenue, consolidated (2016) 2016-12-31)
  Profit 1,187,075,000 (2016-12-31)
  Cash 307,023,000 (2016-12-31)
     
    * Document for �About Section�: Genmab A/S. (12/4/13). "Press Release: Genmab Announces Expansion of DuoBody Platform Collaboration with Janssen Biotech, Inc.". Copenhagen.
     
   
Record changed: 2018-10-30

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Genmab (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top